Exempt vs. Expedited vs. Full Ethics Review: What’s the Difference?

What Is the Difference Between Exempt, Expedited, and Full Review?

You submit a protocol and hear that it may be “exempt,” qualify for “expedited review,” or require “full review.” The labels sound like a progression from no review, to fast review, to serious review. That interpretation is tempting, and frequently wrong.

These terms describe different review pathways within particular research-ethics systems. They affect who reviews a protocol and how the review is conducted, but they should not be treated as grades for how ethical, important, or scientifically sophisticated a study is.

The Three Categories Describe Different Review Pathways

How Exempt, Expedited, and Full Review Differ

Exempt From Review

Exemption is a defined status under an applicable ethics framework. A study must satisfy the conditions established for an exemption rather than merely appear simple or harmless.

In the 2022 Philippine National Ethical Guidelines, “Exempt from Review” means that a protocol does not need full or expedited review after preliminary assessment by a designated REC member. The REC Chair or representative determines exemption or the kind of review required, and exemption is expressly described as a decision made by the REC.

Under the U.S. Common Rule, specific categories of human-subject research are exempt from regulatory requirements when their conditions are satisfied. Some of these categories nevertheless require limited IRB review.

So “exempt” should not automatically be translated as “nobody from the ethics system ever looks at this study.”

Expedited Review

The word expedited is perhaps the most misleading of the three labels because ordinary English makes it sound like express processing.

In research ethics, expedited review refers primarily to the review procedure. Under U.S. federal rules, eligible research can be reviewed by the IRB chair or one or more experienced reviewers designated by the chair instead of being considered by the convened IRB. The federal expedited categories apply to specified research activities that involve no more than minimal risk, subject to the applicable conditions.

Philippine ethics guidance likewise distinguishes expedited review from full committee review. Earlier national guidance makes the point especially plainly: expedited review refers to the number of REC members conducting the initial review rather than the amount of time the review takes.

Full Review

Full review, often called full-board or convened review in some systems, involves consideration by the research ethics committee or IRB through its formal meeting process rather than solely through designated expedited reviewers.

Under Philippine national guidance, the REC Chair or representative determines whether a protocol requires full or expedited review. The framework considers risk and vulnerability among the factors relevant to review classification.

Full review allows the committee collectively to consider ethical issues that may require broader expertise and deliberation. Depending on the study, these can concern interventions, significant risks, sensitive procedures, vulnerable participants, difficult risk-benefit judgments, or other issues requiring committee discussion.

The Three Pathways Side by Side

Minimal Risk Helps Determine the Pathway, but It Does Not Decide Everything

Minimal risk is a central concept in many ethics frameworks. Broadly, it compares the probability and magnitude of anticipated research harms or discomforts with a defined benchmark, although the exact regulatory definition should always be taken from the governing system.

It would be a mistake, however, to turn review classification into a one-line formula:

minimal risk = exempt; slightly more risk = expedited; high risk = full review.

That is not how these categories work. Exemption normally depends on satisfying specified categories and conditions. Expedited review likewise requires eligibility under the applicable rules. Other characteristics, including vulnerability, identifiability, sensitive information, interventions, and regulatory requirements, can affect the appropriate pathway.

Exempt and Expedited Are Not the Same Thing

Both can involve studies presenting relatively limited risk, which makes the categories easy to confuse. The procedural difference is important.

An exempt protocol satisfies a particular exemption provision. An expedited protocol remains subject to ethics review but is eligible to be reviewed through a streamlined mechanism rather than through the full convened committee process.

A study can therefore be minimal risk but fail to qualify for exemption and still be appropriate for expedited review.

Expedited Review Uses the Same Ethical Standards

Expedited does not mean abbreviated ethics. Under U.S. regulations, an expedited reviewer may exercise the IRB's authority except that the reviewer may not disapprove the research. A research activity can be disapproved only after review through the convened IRB procedure.

Likewise, ordinary requirements such as informed consent do not disappear merely because expedited review is used. FDA guidance explicitly notes that standard informed-consent requirements, including applicable waivers, alterations, or exceptions, apply regardless of whether expedited or convened review is used.

Full Review Does Not Mean the Study Is Unethical

A protocol sent for full review has not failed an ethics test. The classification means that the applicable system requires or considers the convened committee process appropriate for that research.

A well-designed clinical trial involving more than minimal risk, for example, may appropriately undergo full review precisely because its ethical questions deserve collective scrutiny. After review and any necessary modifications, the committee may approve it.

Conversely, exemption is not a certificate that a study is ethically superior. Review category and ethical quality are different concepts.

Review Classification Is Not Chosen for Convenience

Researchers understandably prefer a simpler process, but review pathways are not menu options. You should not rewrite a classification request around whichever pathway seems fastest.

Under Philippine national guidance, the REC Chair or representative determines exemption or whether full or expedited review is required. The U.S. system similarly establishes regulatory conditions for exempt and expedited research rather than allowing investigators to select whichever process they prefer.

If you believe your protocol qualifies for an exemption, the relevant question is who is authorized to make that determination, not whether you personally feel comfortable calling it exempt.

The Same Study Can Be Classified Differently Under Different Systems

“Exempt,” “expedited,” and “full review” are not globally standardized labels with identical criteria everywhere. National regulations, institutional policies, participant populations, research settings, and the nature of the study can produce different classifications.

This is especially important in international or multisite research. A protocol that qualifies for a particular pathway at one institution should not automatically be assumed to have the same status elsewhere.

How Small Changes Can Affect the Review Pathway

The lesson is not that questionnaires are always exempt, interviews are always expedited, and interventions always receive full review. They are not. Classification follows the actual protocol and applicable criteria, not the method's name.

Common Misunderstandings About Ethics Review Categories

Think About Eligibility, Not Which Pathway You Prefer

Before submission, identify the features likely to affect classification, but avoid treating your own assessment as the final determination when your ethics system assigns that responsibility elsewhere.

The practical objective is not to secure the lightest review category. It is to obtain the appropriate determination before beginning the research activities for which prior ethics clearance is required.

Before Predicting Your Ethics Review Pathway

Frequently Asked Questions About Ethics Review Pathways

The Categories Describe How Ethics Review Is Conducted

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.